Elevated interferon-gamma in CNS inflammatory disease: A potential complication for bone marrow reconstitution in MS

Journal of Neuroimmunology

Volumn 108, Issue 1-2, 2000, Pages 40-44

  Hassan Zahraee, Mina ^a   Tran, Elise H ^a   Bourbonnière, Lyne ^a   Owens, Trevor ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Bone marrow transplantation; Cytokine expression; Inflammatory disease; Multiple sclerosis

Indexed keywords

CYTOKINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; INFLAMMATION; INTERFERON TYPE II; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERFERON; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; SURVIVAL RATE; TRANSGENES; TRANSPLANTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034255743     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00263-5     Document Type: Article

References (26)

1. Balashov, K.E., Smith, D.R., Khoury, S.J., Hafler, D.A., Werner, H.L., 1997. Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD4O ligand. Proc. Natl. Acad. Sci. USA 94, 599-603.
2. Becher, B., Giacomini, P.S., Pelletier, D., McCrea, E., Prat, A., Antel, J.P., 1999. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy. Ann. Neurol. 45, 247-250.
3. Boehm, U., Klamp, T., Groot, M., Howard, J.C., 1997. Cellular responses to interferon-g. Ann. Rev. Immunol. 15, 749-795.
4. Brok, H.P., Heidt, P.J., van der Meide, P.H., Zurcher, C., Vossen, J.M., 1993. Interferon-gamma prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151, 6451-6459.
5. Brok, H.P., Vossen, J.M., Heidt, P.J., 1997. Interferon-gamma-mediated prevention of Graft-versus-host disease: development of immune competent and allo-tolerant T cells in chimeric mice. Bone Marrow Transplant. 19, 601-606.
6. Ferrara, J.L., Cooke, K.R., Pan, L., Krenger, W., 1996. The immunopathophysiology of acute graft-versus-host-disease. Stem Cells 14, 473-489.
7. Goes, N., Urmson, J., Hobart, M., Halloran, P.F., 1996. The unique role of Interferon-gamma in regulation of MHC expression on arterial endothelium. Transplantation 62, 1889-1894.
8. Ijzermans, J.N., Bouwman, E., de Bruin, R.W., Jeekel, J., Marquet, R.L., 1991. Treatment with rIFN-gamma has no effect on cardiac allograft rejection. Immunology 73, 243-245.
9. Kappler, J.W., Skidmore, B., White, J., Marrack, P., 1981. Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition. J. Exp. Med. 153 (5), 1198-1214.
10. Krakowski, M., Owens, T., 1997. The central nervous system environment controls effector CD4+ T cell cytokine profile in experimental allergic encephalomyelitis. Eur. J. Immunol. 27, 2840-2847.
11. Krenger, W., Falzarano, G., Delmonte, Jr. J., Synder, K.M., Byon, J.C., Ferrara, J.L., 1996. Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease. Blood 88, 1113-1121.
12. Murphy, W.J., Welniak, L.A., Taub, D.D., Wlltrout, R.H., Taylor, P.A., Vallera, D.A., Kopf, M., Young, D.L., Blazar, B.R., 1998. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Clin. Invest. 102, 1742-1748.
13. Myers, K.J., Dougherty, J.P., Ron, Y., 1993. In vivo antigen presentation by both brain parenchymal cells and hematopoietically derived cells during the production of experimental autoimmune encephalomyelitis. J. Immunol. 151, 2252-2260.
14. O'Garra, A., 1998. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8, 275-283.
15. Ozato, K., Mayer, N., Sachs, D.H., 1980. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J. Immunol. 124 (2), 533-540.
16. Ozato, K., Mayer, N.M., Sachs, D.H., 1982. Monoclonal antibodies to mouse major histocompatibility complex antigens. Transplantation 34 (3), 113-120.
17. Panitch, H.S., Hirsch, R.L., Haley, A.S., Johnson, K.P., 1987. Exacerbations of multiple sclerosis in patients treated with gamma interferon. Lancet 1 (8538), 893-895.
18. Pinel, M.I., Esteves, E.B., Rumjanek, V.M., 1998. Natural killer cell activity in Hodgkin's disease patients undergoing radiation therapy or chemotherapy and radiation. Clin. Lab. Haem. 20, 303-306.
19. Raisanen-Sokolowski, A., Glysing-Jensen, T., Koglin, J., Russell, M.E., 1998. Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients. Am. J. Pathol. 152, 359-365.
20. Renno, T., Taupin, V., Bourbonniere, L., Verge, V., Tran, E., Simone, R., Krakowski, M., Rodriguez, M., Peterson, A., Owens, T., 1998. Interferon-g in progression to chronic demyelination and neurological deficit following acute EAE. Mol. Cell. Neurosci. 12, 376-389.
21. Sandberg, J.O., Benda, B., Lycke, N., Korsgren, O., 1997. Xenograft rejection of porcine islet-like cell clusters in normal, interferon-gamma, and interferon-gamma receptor deficient mice. Transplantation 63, 1446-1452.
22. Taupin, V., Renno, T., Bourbonniere, L., Peterson, A., Rodriguez, M., Owens, T., 1997. Increased severity of EAE, chronic macrophage/ microglia reactivity and demyelination in transgenic mice producing tumor necrosis factor-a in central nervous system. Eur. J. Immunol. 27, 905-1013.
23. Tran, E.H., Hoekstra, K., van Rooijen, N., Dijkstra, C.D., Owens, T., 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161, 3767-3775.
24. Tyndall, A., Gratwohl, A., 1997. Hemopoietic blood and marrow transplants in the treatment of severe autoimmune disease. Curr. Opin. Hem. 4, 390-394.
25. Wall, D.A., Sheehan, K.C., 1994. The role of tumor necrosis factor and interferon gamma in graft-versus-host disease and related immunodeficiency. Transplantation 57, 273-279.
26. Woerly, G., Roger, N., Loiseau, S., Dombrowicz, D., Capron, A., Capron, M., 1999. Expression of CD28 and CD86 by human eosinophils and role in the secretion of type 1 cytokines (interleukin 2 and interferon gamma): inhibition by immunoglobulin A complexes. J. Exp. Med. 190, 487-495.